Andrew Torres, PhD

VP of CMC at Aurion Biotech

Speaker

Andrew Torres leads all things CMC at Aurion Biotech. Andrew has a deep background in process, analytical, formulation, CMC regulatory strategy and operations, quality control, supply chain and GMP manufacturing. Before joining Aurion Biotech, Andrew held leadership roles at Molecular Templates, Neoleukin Therapeutics, Regeneron, and GE Global Research, where as a lead scientist he supported numerous projects for both government and industry. Andrew holds more than 30 patents and has authored numerous scientific articles. Andrew obtained a PhD in chemistry and biochemistry from Northwestern University.